Stay updated with breaking news from Global External. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from INVENTIVA, Inventiva receives a €4 million milestone payment from AbbVie for cedirogant Phase IIb initiation
Daix (France), Long Island City (New York, United States), January 20, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small
Investegate announcements from INVENTIVA, Inventiva announces participation at several conferences in January and February 2022
Investegate announcements from INVENTIVA, Inventiva to present at the 40th Annual J.P. Morgan Healthcare Conference
Daix (France), Long Island City (New York), December 16, 2021 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule